Q2 2023 Holdings
Filed 2023-08-14 | 72 holdings | $2.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $334.6M | 17,730,417 | 12.8% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $301.3M | 2,566,661 | 11.6% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $245.8M | 19,566,961 | 9.4% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $102.6M | 4,420,533 | 3.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $84.6M | 1,811,672 | 3.2% |
| Augmedix Inc(AUGX) | COM | 05105P107 | $75.2M | 15,630,327 | 2.9% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $68.7M | 4,878,566 | 2.6% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $62.5M | 13,124,427 | 2.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $57.5M | 1,696,004 | 2.2% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $56.6M | 1,100,492 | 2.2% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $50.4M | 1,162,166 | 1.9% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $48.9M | 5,661,230 | 1.9% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $48.5M | 2,678,099 | 1.9% |
| Penumbra Inc(PEN) | COM | 70975L107 | $47.8M | 138,970 | 1.8% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $47.4M | 1,485,199 | 1.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $43.1M | 1,120,476 | 1.7% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $43.0M | 1,868,507 | 1.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $42.4M | 489,208 | 1.6% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $42.4M | 341,882 | 1.6% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $42.0M | 3,955,188 | 1.6% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $40.5M | 2,026,576 | 1.6% |
| Dexcom Inc(DXCM) | COM | 252131107 | $37.2M | 289,161 | 1.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $36.4M | 1,921,152 | 1.4% |
| Elevance Health Inc(ELV) | COM | 036752103 | $34.8M | 78,313 | 1.3% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $33.2M | 4,403,840 | 1.3% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $30.8M | 940,493 | 1.2% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $30.2M | 14,049,935 | 1.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $28.5M | 2,857,309 | 1.1% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $27.4M | 2,971,542 | 1.1% |
| Stryker Corporation(SYK) | COM | 863667101 | $26.2M | 85,899 | 1.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $25.7M | 2,428,335 | 1.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $24.3M | 2,053,333 | 0.9% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $24.0M | 114,351 | 0.9% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $22.0M | 151,372 | 0.8% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $21.2M | 94,409 | 0.8% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $21.2M | 391,178 | 0.8% |
| Humana Inc(HUM) | COM | 444859102 | $20.7M | 46,310 | 0.8% |
| Verve Therapeutics Inc | COM | 92539P101 | $19.9M | 1,061,960 | 0.8% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $19.9M | 1,311,572 | 0.8% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $19.4M | 1,324,350 | 0.7% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $17.7M | 1,370,299 | 0.7% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $17.5M | 5,619,914 | 0.7% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $14.4M | 761,955 | 0.6% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $13.4M | 6,860,226 | 0.5% |
| Annexon Inc(ANNX) | COM | 03589W102 | $12.3M | 3,503,190 | 0.5% |
| Absci Corporation(ABSI) | COM | 00091E109 | $12.2M | 8,031,094 | 0.5% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $10.0M | 2,283,594 | 0.4% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $9.8M | 6,373,898 | 0.4% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $9.7M | 6,048,123 | 0.4% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $9.6M | 1,283,289 | 0.4% |